Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7:
Frontiers in Clinical Drug Research - Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the series covers a range of topics i...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Piraí
Bentham Science Publishers
2023
|
Schriftenreihe: | Frontiers in Clinical Drug Research - Diabetes and Obesity Series
Volum 7 |
Schlagworte: | |
Online-Zugang: | DE-19 |
Zusammenfassung: | Frontiers in Clinical Drug Research - Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The sixth volume of this series features 6 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist. - The failing heart in diabetes with special emphasis on prevention- Flavonoids as prominent anti-diabetic agents- Chemosensor in glucose monitoring, advances and challenges - Synergistic drugs and polyherbal formulations for obesity: current status and future prospectives- Urge for herbal anti-diabetic medicines towards clinical and therapeutic implications- Curcuma longa as a dietary supplement and medication for diabetes mellitus: evidence from experimental studies. |
Beschreibung: | 1 Online Ressource (228 Seiten) |
ISBN: | 9789815123586 |
Internformat
MARC
LEADER | 00000nmm a22000001cb4500 | ||
---|---|---|---|
001 | BV049867785 | ||
003 | DE-604 | ||
007 | cr|uuu---uuuuu | ||
008 | 240916s2023 |||| o||u| ||||||eng d | ||
020 | |a 9789815123586 |9 978-981-5123-58-6 | ||
035 | |a (OCoLC)1456125856 | ||
035 | |a (DE-599)KEP091406404 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-19 | ||
084 | |a PZ 4700 |0 (DE-625)141182: |2 rvk | ||
100 | 1 | |a Anjum, Shazia |e Verfasser |0 (DE-588)1104402084 |4 aut | |
245 | 1 | 0 | |a Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 |
264 | 1 | |a Piraí |b Bentham Science Publishers |c 2023 | |
300 | |a 1 Online Ressource (228 Seiten) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Frontiers in Clinical Drug Research - Diabetes and Obesity Series |v Volum 7 | |
520 | 3 | |a Frontiers in Clinical Drug Research - Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The sixth volume of this series features 6 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist. - The failing heart in diabetes with special emphasis on prevention- Flavonoids as prominent anti-diabetic agents- Chemosensor in glucose monitoring, advances and challenges - Synergistic drugs and polyherbal formulations for obesity: current status and future prospectives- Urge for herbal anti-diabetic medicines towards clinical and therapeutic implications- Curcuma longa as a dietary supplement and medication for diabetes mellitus: evidence from experimental studies. | |
653 | 0 | |a Electronic books | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789815123593 |
912 | |a ZDB-30-PQE | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-035207329 | |
966 | e | |u https://ebookcentral.proquest.com/lib/ub-lmu/detail.action?docID=30494941 |l DE-19 |p ZDB-30-PQE |q UBM_Einzelkauf_2023 |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1812974105994985472 |
---|---|
adam_text | |
any_adam_object | |
author | Anjum, Shazia |
author_GND | (DE-588)1104402084 |
author_facet | Anjum, Shazia |
author_role | aut |
author_sort | Anjum, Shazia |
author_variant | s a sa |
building | Verbundindex |
bvnumber | BV049867785 |
classification_rvk | PZ 4700 |
collection | ZDB-30-PQE |
ctrlnum | (OCoLC)1456125856 (DE-599)KEP091406404 |
discipline | Rechtswissenschaft |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nmm a22000001cb4500</leader><controlfield tag="001">BV049867785</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">240916s2023 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789815123586</subfield><subfield code="9">978-981-5123-58-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1456125856</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KEP091406404</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PZ 4700</subfield><subfield code="0">(DE-625)141182:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Anjum, Shazia</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1104402084</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Piraí</subfield><subfield code="b">Bentham Science Publishers</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online Ressource (228 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Frontiers in Clinical Drug Research - Diabetes and Obesity Series</subfield><subfield code="v">Volum 7</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Frontiers in Clinical Drug Research - Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The sixth volume of this series features 6 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist. - The failing heart in diabetes with special emphasis on prevention- Flavonoids as prominent anti-diabetic agents- Chemosensor in glucose monitoring, advances and challenges - Synergistic drugs and polyherbal formulations for obesity: current status and future prospectives- Urge for herbal anti-diabetic medicines towards clinical and therapeutic implications- Curcuma longa as a dietary supplement and medication for diabetes mellitus: evidence from experimental studies.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Electronic books</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789815123593</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PQE</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-035207329</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://ebookcentral.proquest.com/lib/ub-lmu/detail.action?docID=30494941</subfield><subfield code="l">DE-19</subfield><subfield code="p">ZDB-30-PQE</subfield><subfield code="q">UBM_Einzelkauf_2023</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV049867785 |
illustrated | Not Illustrated |
indexdate | 2024-10-15T10:07:21Z |
institution | BVB |
isbn | 9789815123586 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-035207329 |
oclc_num | 1456125856 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | 1 Online Ressource (228 Seiten) |
psigel | ZDB-30-PQE ZDB-30-PQE UBM_Einzelkauf_2023 |
publishDate | 2023 |
publishDateSearch | 2023 |
publishDateSort | 2023 |
publisher | Bentham Science Publishers |
record_format | marc |
series2 | Frontiers in Clinical Drug Research - Diabetes and Obesity Series |
spelling | Anjum, Shazia Verfasser (DE-588)1104402084 aut Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 Piraí Bentham Science Publishers 2023 1 Online Ressource (228 Seiten) txt rdacontent c rdamedia cr rdacarrier Frontiers in Clinical Drug Research - Diabetes and Obesity Series Volum 7 Frontiers in Clinical Drug Research - Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The sixth volume of this series features 6 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist. - The failing heart in diabetes with special emphasis on prevention- Flavonoids as prominent anti-diabetic agents- Chemosensor in glucose monitoring, advances and challenges - Synergistic drugs and polyherbal formulations for obesity: current status and future prospectives- Urge for herbal anti-diabetic medicines towards clinical and therapeutic implications- Curcuma longa as a dietary supplement and medication for diabetes mellitus: evidence from experimental studies. Electronic books Erscheint auch als Druck-Ausgabe 9789815123593 |
spellingShingle | Anjum, Shazia Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 |
title | Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 |
title_auth | Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 |
title_exact_search | Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 |
title_full | Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 |
title_fullStr | Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 |
title_full_unstemmed | Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 |
title_short | Frontiers in Clinical Drug Research - Diabetes and Obesity, Volume 7 |
title_sort | frontiers in clinical drug research diabetes and obesity volume 7 |
work_keys_str_mv | AT anjumshazia frontiersinclinicaldrugresearchdiabetesandobesityvolume7 |